| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |